“Boost your cellular energy.” “Support your cell’s powerhouse.” “Recharge your body at the source.”
Phrases like these are everywhere in health marketing, all built on a simple idea: if mitochondria are the engines of our cells, then helping them work better should translate into more energy, better health, and maybe even slower aging. It sounds scientific, and just familiar enough to feel credible. You may not remember much biochemistry, but you’ve probably heard of mitochondria.
But what does it actually mean to “support” something inside our cells? And more importantly, is there any persuasive, credible evidence that treatments aimed at “mitochondrial support” do anything that actually matters?
The energy appeal
There is a kernel of scientific truth behind the marketing. Mitochondria generate adenosine triphosphate (ATP), the molecule that powers nearly every energy-dependent process in the body. Tissues with high energy demands (muscle, brain, and heart) are packed with mitochondria. When mitochondrial function is impaired, as seen in rare inherited mitochondrial disorders, the clinical consequences can be profound.
From there, the logic is extrapolated: if mitochondrial activity is linked to cellular energy, then enhancing that activity should translate into you feeling more energized. It’s a short step from there to broader claims about well-being and even aging itself. We’ve seen similar arguments before: telomeres, hormones, and other biological markers positioned as levers we can pull, or dials we can adjust, to optimize “wellness” and slow decline.
But this reasoning skips several critical steps.
What mitochondria actually do
To assess the claims about “boosting” mitochondria, it’s helpful to have better understanding of what they actually do. Mitochondria are involved in several essential cellular processes beyond energy production.
- Energy production: Through oxidative phosphorylation, mitochondria convert nutrients into ATP, providing the energy required for nearly every biological process.
- Regulation of cell death: Mitochondria play a central role in apoptosis, the controlled elimination of damaged or unnecessary cells. This process is critical for maintaining healthy tissues and preventing disease.
- Calcium signaling: By taking up and releasing calcium ions, mitochondria help regulate muscle contraction, nerve transmission, and other calcium‑dependent cellular activities.
- Reactive oxygen species (ROS) management: Mitochondria produce reactive oxygen species as a byproduct of energy metabolism. They also contribute to controlling ROS levels, supporting normal signaling while limiting oxidative damage.
Mitochondria are fundamental to life. Their essential roles mean that no simple supplement, device or treatment is likely to dramatically alter their function. At the same time, their complexity sets limits on what targeted interventions can achieve: changes that may be observed at the cellular level do not automatically translate into improvements we can identify.
The evidence ladder: Biochemical → Functional → Clinical
When evaluating claims about mitochondrial support and energy, it helps to think in terms of three levels of evidence: biochemical, functional, and clinical. Different fields may use different labels, but you can think of this as additive and progressive. (It ties into why we call this blog Science-Based Medicine). Each level tells us something different, and problems arise when results at one level are implied as proof for the next.
- Biochemical evidence: This is the most basic level. It measures molecular or cellular changes—ATP production, NAD⁺ levels, enzyme activity, or markers of oxidative stress. Biochemical studies are often conducted in isolated cells or animal models, and sometimes in human tissues or blood samples, but they still tell us what could happen under controlled conditions rather than what reliably happens in living humans.
- Functional evidence: This level looks at measurable outcomes that reflect how the body actually performs—exercise endurance, muscle strength, cognitive tests, or fatigue scores. It could also include the measurement of a surrogate – something that isn’t itself meaningful to a patient. Functional studies can be done in humans and measure real performance, but they do not necessarily indicate durable or clinically meaningful benefits.
- Clinical evidence: This is what we’re looking for. Outcomes that matter: disease progression, symptom relief, quality of life, or lifespan. Clinical evidence demonstrates that a treatment actually improves health in a meaningful way.
The challenge is that many “mitochondrial support” products and interventions never progress beyond the biochemical level. A supplement might change a value in a test tube or even in blood samples, but that does not guarantee any functional benefit, let alone a clinical effect. Marketing often implies that biochemical changes are automatically beneficial for health, skipping the intermediate questions that only functional studies and clinical trials can answer.
Understanding this hierarchy is essential for evaluating claims critically. Just because mitochondria are important doesn’t mean that boosting a cellular marker will make you feel more energetic, healthier, or younger. Without functional or clinical evidence, these claims remain speculative at best.
Products marketed for your mitochondria
NAD⁺ and Precursors
Nicotinamide adenine dinucleotide (NAD⁺) is a critical coenzyme in energy metabolism, and its levels do decline with age. Supplements like nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) can raise NAD⁺ in blood or tissues in small human studies. But there’s little persuasive evidence that this translates into measurable improvements in energy, cognition, or aging in healthy adults. The effect remains largely biochemical, with functional or clinical benefits remaining unproven.
Coenzyme Q10
CoQ10 is a supplement that’s been popular for decades, without convincing evidence that popularity is warranted. It is essential for the electron transport chain, and has a role in mitochondrial energy production. Some evidence supports its use in specific conditions, like statin-associated muscle symptoms or certain rare mitochondrial diseases. For general fatigue or wellness in healthy individuals, however, the clinical evidence is weak or inconsistent. A biochemical effect does not automatically result in noticeable health improvements.
Red Light Therapy (Photobiomodulation)
I see influencers love red light therapy. Red or near-infrared light can be absorbed by mitochondrial enzymes in lab studies, potentially increasing ATP production and modulating ROS. Small human studies suggest modest improvements in localized pain, wound healing, or exercise recovery, but results are inconsistent and often poorly controlled. Evidence that it meaningfully boosts overall mitochondrial function or systemic energy in healthy people is lacking.
The marketing works
When you hear the term “mitochondrial dysfunction” used outside of a medical diagnosis, it’s usually as an explanation for common and non-specific complaints: fatigue, brain fog, low mood, or general malaise. It’s a convenient placeholder – it sounds scientific!
This vagueness is precisely what makes the marketing effective. The language is plausible, borrowing legitimacy from real biology. Subjective outcomes like energy and wellness are difficult to measure and easy to claim improvement in, which lowers the bar for perceived effectiveness. And add in placebo effects. If you’re investing in a treatment, you want it to work. The interventions themselves often feel harmless, like taking a supplement, or boosting your exposure to red light. Combine biological plausibility, personal relevance, and low perceived risk, and you have a powerful marketing formula.
What good evidence looks like
If a treatment genuinely “supports” mitochondria in a meaningful way, it would not be impossible to measure. But the evidence needs to go beyond cell cultures or blood biomarkers. Ideally, it would include:
- Well-designed human trials: Randomized, placebo-controlled studies in clearly defined populations.
- Functional outcomes: Measures that reflect real-world performance, such as exercise endurance, cognitive testing, or fatigue scales.
- Clinically meaningful endpoints: Improvements in symptoms, quality of life, or disease progression, not just laboratory markers.
- Sustained effects and replication: Benefits should be durable over time and consistently appear over multiple trials.
In short, good evidence links changes in mitochondrial biology to actual, measurable improvements in how people feel or function. Without this, these claims are speculative and unproven.
Mitochondria matter, but…
If your mitochondria weren’t working, you wouldn’t be reading this post. The question isn’t whether mitochondria are important. It’s whether they need any distinct “support.” Until objective evidence for mitochondria support treatments demonstrate meaningful clinical benefits, “supporting your mitochondria” will remains a marketing term, not a medical one.